5391 - 5400 of 6560 Results
Title
Year
-
OPENTitle: Application of new biologic disease criteria for synucleinopathies to the systemic synuclein sampling study cohortJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 69End Page: 69Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00919-yBest OA location URL: https://www.nature.com/articles/s41531-025-00919-y.pdfCitation Count: 1
-
OPENTitle: Tet2 loss and enhanced ciliogenesis suppress α-synuclein pathologyJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 71End Page: 71Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s40478-025-01988-zBest OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-025-01988-zCitation Count: 5
-
OPENTitle: Use of receptor and nonreceptor tyrosine kinase inhibitors and Parkinson disease riskJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 23Issue #: 5Start Page: e01040End Page: e01040Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurot.2026.e01040Best OA location URL: https://doi.org/10.1016/j.neurot.2026.e01040Citation Count: 0
-
OPENTitle: Review: Circadian disruption, chronotherapy, and deep brain stimulation (DBS) in Parkinson’s disease (PD)Journal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-026-01533-2Best OA location URL: https://doi.org/10.1038/s41531-026-01533-2Citation Count: 0
-
OPENTitle: Electroencephalographic slowing during REM sleep as a marker of cholinergic network dysfunction in Lewy body disordersJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-026-01515-4Best OA location URL: https://www.nature.com/articles/s41531-026-01515-4_reference.pdfCitation Count: 0
-
OPENTitle: Alanine tRNA fragments interacting with MEG3 long splice variant show tissue-, cellular compartment- and disease severity-dependent changes in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-026-01541-2Best OA location URL: https://www.nature.com/articles/s41531-026-01541-2_reference.pdfCitation Count: 0
-
OPENTitle: Brain‐derived plasma p‐tau217 shows enhanced dynamic range for Alzheimer's disease neuropathological changeJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 22Issue #: 9Start Page: e71773End Page: e71773Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.71773Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.71773Citation Count: 0
-
OPENTitle: Network-based analyses identify GFAP as a cross-domain hub linking synaptic, neuronal, and inflammatory CSF markers in Alzheimer’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-026-67701-9Best OA location URL: https://doi.org/10.1038/s41598-026-67701-9Citation Count: 0
-
OPENTitle: SNCA-targeted transcriptional repression therapy alleviates pathological and behavioral perturbations in a Parkinson's disease mouse modelJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 23Issue #: 5Start Page: e01049End Page: e01049Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurot.2026.e01049Best OA location URL: https://doi.org/10.1016/j.neurot.2026.e01049Citation Count: 0
-
OPENTitle: Multi-omics comparative analyses of synucleinopathy models reveal distinct drug targets and relevance for drug developmentJournal Name: Discover NeurosciencePublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s13064-026-00321-1Best OA location URL: https://doi.org/10.1186/s13064-026-00321-1Citation Count: 0